Although King Charles’ cancer treatment is reported to be “moving in a positive direction”, the Monarch will continue therapy into the new year to manage his condition.
The King’s health concerns first came to light earlier this year during a hospital stay for a procedure related to benign prostate enlargement.
Subsequent tests revealed the presence of cancer, prompting the King to commence a schedule of regular treatments.
While he was able to return to public duties two months later, the number of engagements has been limited on medical advice.
As Charles returns to public life and his royal duties, a palace source revealed that his treatment would continue in 2025.
“His treatment has been moving in a positive direction and as a managed condition the treatment cycle will continue into next year,” a palace source revealed.
Despite his health challenges, Charles was recently praised for his dedication to his royal duties in the face of adversity by royal commentator Ingrid Seward.
“King Charles is very keen to make up for lost time,” she told GB News.
“He’s done very little travelling this year because of his cancer scare but they’re very strong.
“These Windsor men, they absolutely can outrun anyone and people that come into the family, for example Camilla finds it hard to keep.
“There’s Charles, who’s got cancer, and he’s been doing all kinds of events.
“I mean, he doesn’t stop.
“He’s 76 and he’s got cancer. We don’t quite know what sort of cancer, but he is doing all these things and Camilla has a chest infection and she’s laid absolutely flat.
“So it just gives you an idea of the energy of the Windsors.”
The past year has been a difficult one for the Royal Family. In addition to learning of King Charles’ cancer battle, royal fans were left shocked when Princess Catherine revealed in an emotional video message that she too was undergoing cancer treatment.
Fortunately, royal watchers were treated to some good news recently when Catherine announced that she had completed her course of preventative chemotherapy for cancer.
– with Reuters.